ACIP voted to recommend use of HibMenCY vaccine in infants at increased risk for meningococcal disease
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline), a new combination (meningococcal and Hib) vaccine, in infants at increased risk for meningococcal disease.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
